Intellectual Property: Why is India silent, as a compromise deal on COVID-19 therapies is worked out
The fact is, Indian and South African interests have diverged; India is not in desperate need of vaccines anymore and hence does not want to …
Testing the CL route
Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs
‘PESTICIDES’ IN DRUGS
Sharad Pawar’s provision for protecting test data in the Pesticides Bill could spill over into trade agreements and hit the drugs industry, too
AI throws patent system into turmoil — especially in drug discovery
Artificial intelligence is overturning the conventional idea of intellectual property rights
Software outsmarts drug research
Now, a programme can bypass patented drug pathways and create synthetically-produced medicines
Wooing the judges, openly
There is conflict of interest as US patent owners schedule meetings with Indian judiciary and patent regulators
US pharma strikes back
Upset by the Supreme Court’s endorsement of India’s patent law, the American drug industry is lobbying with Obama to tighten the …
Encouraging orphan drugs in India
India needs to formulate an atrractive law to spur development of drugs for rare diseases
Hypocrisy of the west
A legitimate tool to meet any public health crisis, rich countries, particularly the US, have resolutely opposed its deployment by developing …
What drives innovation?
The new Intellectual Property Rights policy is based on a tenuous premise that having more IPRs will result in more innovation
New ruse in Big Pharma's old game
Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics
दवा की बड़ी कंपनियों की लाॅबिंग के पीछे का कड़वा सच
अमेरिकी दवा कंपनियां चाहती हैं कि कोविड-19 वैक्सीन या दवाओं को बौद्धिक संपदा अधिकार के दायरे से बाहर रखने की भारत की मांग को ...
How to save $25 billion and more on drug costs
Patent settlements bring cheaper generics to market early and cut healthcare spending
Strong medicine for weak drug patents
Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend
Curing the ills of pharma FDI
Foreign investment in existing pharma companies will be allowed with riders
Yale guide to fighting drug patent barriers
How human rights can be used to challenge oppressive intellectual property laws
क्या मेडिकल पेटेंट का भयावह इतिहास रच रही है दवा कंपनी फाइजर?
दवाओं को वैश्विक बौद्धिक संपदा व्यवस्था में लाना फाइजर की अगुवाई में कॉर्पोरेट धोखाधड़ी की जीत थी